Palisade Bio

$PALI is leading the Prism MarketView Biotech index and is up over 100% currently after the company announced it has decided to cancel a proposed $5 million offering and possibly enact a reverse split.

Share This Article

 

About the Author

Palisade Bio

Joey Ramson